ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) jumped higher at $4.46, a gain of 26.7%. The stock got featured on our News Catalysts scanner on Thu 25 Feb 21 at 07:28 AM in the 'PRIVATE PLACEMENT' category. From Wed 10 Feb 21, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Tue 16 Feb 21 at $4.28 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- PAND (PAND:NASDAQ), 133.36%
- ChromaDex Corporation (CDXC:NASDAQ), 92.4%
- TDH Holdings, Inc. (PETZ:NASDAQ), 34.73%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 26.7%
- Dynatronics Corporation (DYNT:NASDAQ), 25%
- Workhorse Group Inc. (WKHS:NASDAQ), 24.72%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%
- GameStop Corp. (GME:NYSE), 18.56%
- Brookdale Senior Living Inc. (BKD:NYSE), 18.53%
- TIRX (TIRX:NASDAQ), 17.11%